New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
12:20 EDTHNR, ITMN, MM, GRMNHigh option volume stocks: HNR ITMN MM GRMN
News For HNR;ITMN;MM;GRMN From The Last 14 Days
Check below for free stories on HNR;ITMN;MM;GRMN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 24, 2014
16:46 EDTHNRGruss Capital reports 5.04% passive stake in Harvest Natural
Subscribe for More Information
July 21, 2014
11:19 EDTITMNInterMune July weekly volatility elevated
Subscribe for More Information
06:17 EDTHNRHarvest Natural signs DOC with Gabon
Subscribe for More Information
July 17, 2014
12:42 EDTITMNInterMune receives FDA Breakthrough Therapy Designation for pirfenidone
InterMune announced that pirfenidone has been granted Breakthrough Therapy Designation from the U.S. FDA. This designation is reserved for drugs that are intended to treat a serious or life threatening disease or condition and preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints. Pirfenidone is an investigational treatment for adult patients with idiopathic pulmonary fibrosis.
July 10, 2014
16:07 EDTHNRHarvest Natural files $300M mixed securities shelf
06:19 EDTGRMNGarmin price target raised to $70 from $65 at Citigroup
Citigroup raised its price target for Garmin shares to $70 saying the company's fitness band vívofit is well positioned to benefit from the faster than expected growth in the activity monitor category. Citi believes 2M-2.5M activity monitors were shipped in Q1, and it expects strong momentum through 2014 and 2015. It reiterates a Buy rating on Garmin.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use